Sacituzumab 是一种人源化 IgG1 单克隆抗体，与抗滋养层细胞表面抗原 2 (anti-Trop-2) 结合。Sacituzumab 具有用于转移性三阴性乳腺癌研究的潜力。
货号:ajcx39776
CAS:1796566-95-4
分子式:N/A
分子量：N/A
溶解度:N/A
纯度：98%
存储：Store at -20°C
库存：现货

Background:

Trastuzumab is a humanized IgG1 monoclonal antibody for anti-trophoblast cell-surface antigen 2 (anti-Trop-2). Sacituzumab has the potential for metastatic triple-negative breast cancer research[1].

[1]. A Bardia, et al. Biomarker analyses in the phase III ASCENT study of sacituzumab govitecan versus chemotherapy in patients with metastatic triple-negative breast cancer. Ann Oncol. 2021 Sep;32(9):1148-1156.